Summary
Overview
Work History
Education
Skills
Affiliations
Timeline
Generic

Brent Rice

San Clemente,CA

Summary

Accomplished biotech and cell therapy executive with broad C-suite and general management experience leading organizations through critical stages of growth, from early clinical development to commercialization. Proven ability to set enterprise strategy, build and scale high-performing organizations, and drive operational execution in complex, global environments. Combines deep industry experience across cell therapy and biopharmaceuticals with a track record of translating innovative science into business success, aligning cross-functional teams, and advancing corporate objectives. Experienced in leading U.S. and European operations, establishing strategic partnerships, and navigating the clinical, regulatory, operational, and commercial challenges required to build successful biotechnology companies.

Overview

37
37
years of professional experience

Work History

Global Chief Commercial Officer

ArriVent BioPharma
San Clemente, CA
09.2025 - Current

Enterprise biotech executive and executive leadership team member serving as chief commercial officer, with broad leadership across commercial strategy, general management and organizational transformation.

  • Built enterprise vision and corporate and portfolio strategy, then guided high-performing teams toward execution and business results.
  • Led P&L management, business development, strategic partnerships, product development, competitive positioning, market expansion, and global go-to-market strategy for innovative therapies from clinical development through commercialization.
  • Developed US and global market readiness and go-to-market plans to improve launch effectiveness.
  • Executive partner with business development team to assess potential collaborations and support strategic alignment.
  • Built hiring roadmap and organization structure for lead asset introduction.
  • Chaired commercial governance committee.

SVP, Global Chief Commercial Officer, Managing Director US

AUTOLUS, Ltd.
San Clemente, CA
10.2018 - 09.2025
  • Built and led US organization, implementing go-to-market commercial strategy for US, EUS, and Japan, driving revenue growth and market penetration.
  • Launched AUCATZYL and secured market leadership in 7 months exceeding forecast by 157%
  • Authorized 33 treatment centers in 4 months covering approximately 60% of the U.S. patient population
  • Secured inclusion of AUCATZYL in NCCN Guidelines within 1 month of FDA approval, enhancing treatment accessibility and positioning in the competitive landscape.
  • First and only CAR-T approved without a REMS (Risk Evaluation Mitigation Strategy) program
  • Chaired US Market Access & Value and Medicare Advisory Group for Alliance for Regenerative Medicine, influencing policy and strategic direction within the regenerative medicine sector.
  • ASTCT Corporate Council Member and 80/20 Initiative

Head US Managed Markets

JUNO THERAPEUTICS
Thousand Oaks, CA
11.2017 - 10.2018
  • Advanced access, pricing, and distribution strategy through comprehensive launch planning for Juno's investigational CAR-T portfolio. Policy, coding, billing, reimbursement, and access readiness improved through stakeholder engagement with CMS, CMMI, Medicare Administrative Contractors, CMS regional offices, commercial insurers, Centers of Excellence, and CAR-T sites. Market access infrastructure strengthened through senior leadership partnership on CAR-T MS-DRG, HCPCS, and CPT code strategy, plus recruitment of account management, payer operations, and payer access support teams.
  • Managed cross-functional teams across JUNO THERAPEUTICS cell therapy operations
  • Developed and implemented strategic plans resulting in achievement of company objectives.
  • Informed business strategy by analyzing market trends and competitor activity.

Executive Director, National Accounts Sales and Marketing

AMGEN, Inc. (United States Value, Access & Reimbursement)
Thousand Oaks, CA
03.2012 - 11.2017
  • Lead National Account Directors (29) responsible for managing multi-million dollar relationships and contracts for National Insurers, Pharmacy Benefit Managers (PBMs), Specialty Pharmacies, Medicare Administrative Contractors (MACs), Medicaid PBMs, State Medicaid Agencies and Employers whose goal is to maximize sales performance and achieve established access and reimbursement objectives across the Amgen portfolio.
  • Executed 3-Year Corporate Value-Based Partnership with Humana, aligning strategic objectives with CEO to enhance collaborative outcomes 2016-2019
  • Exceeded Corporate Gross-to-Net objectives and received special Bonus and Award Trip 2016-2017
  • Developed Peri-Launch plan for new cardiovascular and oncology pipeline products, ensuring effective market entry and stakeholder engagement 2014-2017
  • Served as National Payor Lead for Amgen Customer Initiative, driving implementation of Global Operating Model to enhance payer collaboration 2014
  • US Victory Award for contributing over $130M to bottom-line via largest commercial re-negotiation 2013

Director, Sales and Marketing

AMGEN, Inc. (United States Value, Access & Reimbursement)
Thousand Oaks, CA
05.2006 - 03.2012

Director, Sales Planning & Operations

AMGEN, Inc. (United States Value, Access & Reimbursement)
Thousand Oaks, CA
12.1999 - 01.2006

Sr. District Manager/ Managed Care Executive

ABBOTT LABORATORIES (Pharmaceutical Product Division)
Abbott Park, IL
10.1994 - 12.1999

Laboratory Research Assistant

GENOME PROJECT, UCLA Molecular Biology Department
11.1989 - 01.1991

Education

MBA -

University of Denver, Daniels Graduate School of Business
01-2003

Certificate - Managing Teams for Innovation and Success

Stanford Graduate School of Business
Palo Alto, CA
01-2001

Certificate - Leadership and Negotiation Institute for Healthcare Executives

Kellogg Graduate School of Management
Chicago, IL
01-1998

BA - Russian Studies

University of California
Los Angeles, CA
01-1990

Third Year - Intensive Russian

University of Washington
Seattle, WA
01-1990

Skills

  • Executive Leadership
  • Strategic Partnerships
  • Commercial Strategy
  • Go to Market
  • Global Launch Sequencing
  • Launch Planning & Execution
  • Business Development
  • P&L
  • Lifecycle Management
  • Market Access and Pricing

Affiliations

  • Executive Influence and Negotiation Strategies, Stanford University
  • Leadership Institute for Health Care Executives, Kellogg Executive Academy for Heath Care Management.
  • Managed Care Institute for Health Care Executives, USC Executive Management Institute in Health Care.
  • Partnerships in Managed Care Approaches and Implementation, University of Chicago
  • Strategic Marketing and Branding of Healthcare, Harvard University
  • Leadership Development and High-Performance Teams, Center for Creative Leadership

Timeline

Global Chief Commercial Officer

ArriVent BioPharma
09.2025 - Current

SVP, Global Chief Commercial Officer, Managing Director US

AUTOLUS, Ltd.
10.2018 - 09.2025

Head US Managed Markets

JUNO THERAPEUTICS
11.2017 - 10.2018

Executive Director, National Accounts Sales and Marketing

AMGEN, Inc. (United States Value, Access & Reimbursement)
03.2012 - 11.2017

Director, Sales and Marketing

AMGEN, Inc. (United States Value, Access & Reimbursement)
05.2006 - 03.2012

Director, Sales Planning & Operations

AMGEN, Inc. (United States Value, Access & Reimbursement)
12.1999 - 01.2006

Sr. District Manager/ Managed Care Executive

ABBOTT LABORATORIES (Pharmaceutical Product Division)
10.1994 - 12.1999

Laboratory Research Assistant

GENOME PROJECT, UCLA Molecular Biology Department
11.1989 - 01.1991

MBA -

University of Denver, Daniels Graduate School of Business

Certificate - Managing Teams for Innovation and Success

Stanford Graduate School of Business

Certificate - Leadership and Negotiation Institute for Healthcare Executives

Kellogg Graduate School of Management

BA - Russian Studies

University of California

Third Year - Intensive Russian

University of Washington
Brent Rice